U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: March 14-20 2021
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: March 14-20 2021

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 03/17/2021
Location: Virtual
Subject: What Physicians Need to Know: COVID-19 Therapeutics
FDA Participant/Group: JOHN FARLEY; SALLY SEYMOUR;
Non FDA Participant/Group: Several members from the American Medical Association

Event Date: 03/18/2021
Location: Virtual
Subject: Update on Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Project
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, and other invited guests

Event Date: 03/19/2021
Location: Virtual
Subject: COVID-19 Therapies and Vaccines
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: Government, industry, and other invited guests

Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner

Event Date: 03/15/2021
Location: Virtual
Subject: Listening Session with ValidCare
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Jeff Lombardo, Keith Aqua, Patrick McCarthy, Robert Kaufmann, Scott Hardin (ValidCare);

Event Date: 03/18/2021
Location: Virtual
Subject: COVID-19 Evidence Accelerator Lab Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and other stakeholders

Event Date: 03/19/2021
Location: Virtual
Subject: Listening Session with MoreBetter, Ltd
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives of MoreBetter, Ltd

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 03/15/2021
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Bob Wolpert (Golden State Foods);

Event Date: 03/17/2021
Location: Virtual
Subject: New Era of Smarter Food Safety
FDA Participant/Group: LARRY MORRIS;
Non FDA Participant/Group: David Fitz, Rebecca Kurtzig, Tom Dowd, Tristan Shannon (KPMG International);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

Event Date: 03/19/2021
Location: Phone Brief
Subject: Inspections Backlog
FDA Participant/Group: MARK ABDOO; ELIZABETH MILLER; DONALD ASHLEY; MICHAEL KOPCHA; WILLIAM DENT;
Non FDA Participant/Group: Energy and Commerce Committee majority staff

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 03/15/2021
Location: Virtual
Subject: Interactive Health Survey Assessment Results
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from Sanofi

Event Date: 03/15/2021
Location: Virtual
Subject: Status Update on Manufacturing and Supply Chain
FDA Participant/Group: DONALD ASHLEY; ELIZABETH MILLER;
Non FDA Participant/Group: Dilip Shanghvi (Sun Pharma); Nilesh Gupta, Vinita Gupta (Lupin); Samina Hamied (Cipla); Pankaj Patel (Zydus Cadila); Shirish Belapure, Sudarshan Jain (IPA); Satish Reddy (Dr. Reddy's Laboratories); Samir Mehta (Torrent Pharma);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/17/2021
Location: Virtual
Subject: House Energy and Commerce Committee, Subcommittee on Oversight and Investigations; Leading the Way Forward: Biden Administration Actions to Increase COVID-19 Vaccinations
FDA Participant/Group: N/A
Non FDA Participant/Group: Committee Members

Event Date: 03/18/2021
Location: Washington, DC
Subject: Senate Health, Education, Labor, and Pensions Committee; Examining Our COVID-19 Response: An Update from Federal Officials
FDA Participant/Group: N/A
Non FDA Participant/Group: Committee Members

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 03/16/2021
Location: Virutal
Subject: International Medical Device Regulators Forum (IMDRF) - Global Diagnostic Imaging, Healthcare IT, and Radiation Therapy Trade Association (DITTA) Joint Virtual Workshop: What to Learn From COVID-19
FDA Participant/Group: MELISSA TORRES;
Non FDA Participant/Group: Industry, academia, and other stakeholders

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 03/15/2021
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: PATRICK MCDERMOTT; WILLIAM FLYNN; JULI ANN PUTNAM; ERROL STRAIN; SIOBHAN DELANCEY; JOHN MUSSMAN; CHARLI LONG; ASHLEY STEEL; JOSHUA HAYES; TIMOTHY SCHELL; NEAL BATALLER; NADINE STEINBERG; JEFFREY GILBERT; ANNE NORRIS; AMBER MCCOIG; MATTHEW LUCIA; SUSAN BRIGHT-PONTE; ANTONIA MONIQUE SENNETT; HEATHER TATE;
Non FDA Participant/Group: Representatives from Keep Antibiotics Working (KAW)

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event

 

Back to Top